Cost-effectiveness of second-generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophrenia

Robert A. Rosenheck; Douglas L. Leslie; Jody Sindelar; Edward A. Miller; Haiqun Lin; T. Scott Stroup; Joseph McEvoy; Sonia M. Davis; Richard S.E. Keefe; Marvin Swartz; Diana O. Perkins; John K. Hsiao; Jeffrey Lieberman

doi:10.1176/ajp.2006.163.12.2080

Cost-effectiveness of second-generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophrenia

Robert A. Rosenheck
, Douglas L. Leslie
, Jody Sindelar
, Edward A. Miller
, Haiqun Lin
, T. Scott Stroup
, Joseph McEvoy
, Sonia M. Davis
, Richard S.E. Keefe
, Marvin Swartz
, Diana O. Perkins
, John K. Hsiao
, Jeffrey Lieberman

Gerontology

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	2080-2089
Number of pages	10
Journal	American Journal of Psychiatry
Volume	163
Issue number	12
DOIs	https://doi.org/10.1176/ajp.2006.163.12.2080
State	Published - Dec 2006

ASJC Scopus Subject Areas

Psychiatry and Mental health

Access to Document

10.1176/ajp.2006.163.12.2080

Cite this

Rosenheck, R. A., Leslie, D. L., Sindelar, J., Miller, E. A., Lin, H., Stroup, T. S., McEvoy, J., Davis, S. M., Keefe, R. S. E., Swartz, M., Perkins, D. O., Hsiao, J. K., & Lieberman, J. (2006). Cost-effectiveness of second-generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophrenia. American Journal of Psychiatry, 163(12), 2080-2089. https://doi.org/10.1176/ajp.2006.163.12.2080

Rosenheck, RA, Leslie, DL, Sindelar, J, Miller, EA, Lin, H, Stroup, TS, McEvoy, J, Davis, SM, Keefe, RSE, Swartz, M, Perkins, DO, Hsiao, JK & Lieberman, J 2006, 'Cost-effectiveness of second-generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophrenia', American Journal of Psychiatry, vol. 163, no. 12, pp. 2080-2089. https://doi.org/10.1176/ajp.2006.163.12.2080

@article{609d8cb5a0fd4ff89cb8afdd7b038799,

title = "Cost-effectiveness of second-generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophrenia",

author = "Rosenheck, \{Robert A.\} and Leslie, \{Douglas L.\} and Jody Sindelar and Miller, \{Edward A.\} and Haiqun Lin and Stroup, \{T. Scott\} and Joseph McEvoy and Davis, \{Sonia M.\} and Keefe, \{Richard S.E.\} and Marvin Swartz and Perkins, \{Diana O.\} and Hsiao, \{John K.\} and Jeffrey Lieberman",

year = "2006",

month = dec,

doi = "10.1176/ajp.2006.163.12.2080",

language = "English",

volume = "163",

pages = "2080--2089",

journal = "American Journal of Psychiatry",

issn = "0002-953X",

publisher = "American Psychiatric Association",

number = "12",

}

TY - JOUR

T1 - Cost-effectiveness of second-generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophrenia

AU - Rosenheck, Robert A.

AU - Leslie, Douglas L.

AU - Sindelar, Jody

AU - Miller, Edward A.

AU - Lin, Haiqun

AU - Stroup, T. Scott

AU - McEvoy, Joseph

AU - Davis, Sonia M.

AU - Keefe, Richard S.E.

AU - Swartz, Marvin

AU - Perkins, Diana O.

AU - Hsiao, John K.

AU - Lieberman, Jeffrey

PY - 2006/12

Y1 - 2006/12

UR - https://www.scopus.com/pages/publications/33846276906

UR - https://www.scopus.com/pages/publications/33846276906#tab=citedBy

U2 - 10.1176/ajp.2006.163.12.2080

DO - 10.1176/ajp.2006.163.12.2080

M3 - Article

C2 - 17151158

AN - SCOPUS:33846276906

SN - 0002-953X

VL - 163

SP - 2080

EP - 2089

JO - American Journal of Psychiatry

JF - American Journal of Psychiatry

IS - 12

ER -

Cost-effectiveness of second-generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophrenia

ASJC Scopus Subject Areas

Access to Document

Other files and links

Fingerprint

Cite this